TrialFrontiers in neurology2025
An open-label, proof-of-mechanism trial evaluating a neuroactive steroid GABA modulator in tinnitus.
Luke S Watson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it